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Abstract
Purpose: To evaluate menorrhagia as a risk factor for compromised visual field
Design: A cross-sectional cohort study
Participants: 25 Menorrhagic patients and 23 non-menorrhagic female subjects
Methods: Patients were recruited from the Obstetrics and Gynaecology clinic and divided into two groups. Those suffer-
ing from active menorrhagia were allocated into the disease group while those had never suffered from menorrhagia con-
stituted the control group. All subjects completed a pictorial blood assessment chart (PBAC) to quantify the severity of their 
menorrhagia. All subjects then underwent an eye examination and investigations including visual field and optical coherent 
tomography.
Main Outcome Measures: The mean PBAC was compared between the disease group and the control group. Correla-
tion analysis was tested between PBAC and visual field global indices.
Results: Subjects suffering from menorrhagia have a compromised performance in visual field when compared with sub-
jects with no menorrhagia. A positive association was observed between the severity of menorrhagia and a poorer visual field 
performance.
Conclusions: Menorrhagia may be a risk factor for visual field defects. Further research is encouraged to evaluate whether 
it may be a risk factor for glaucoma development or progression.
Keywords: Visual field; Menorrhagia; Glaucoma; Reperfusion injury; Vascular factors
Synopsis: Subjects suffering from menorrhagia have a compromised performance in visual field when compared with 
subjects with no menorrhagia. A positive association was observed between the severity of menorrhagia and a poorer visual 
field performance.
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Introduction
 Glaucoma arises from accelerated apoptosis of retinal 
ganglion cell (RGC) axons, resulting in an optic neuropathy 
with specific optic nerve (ON) head and visual field damages. 
While increased intraocular pressure (IOP) is a major risk fac-
tor, increasing evidence point towards haemodynamic distur-
bance and neurovascular coupling playing a major role as well.
 Two main theories for glaucoma pathogenesis have 
been described. The mechanical theory stresses that increased 
IOP places mechanical shear and damage on RGC axons. 
The vascular theory implies insufficient ocular blood supply 
precedes glaucomatous damage, and is the result of either an 
increased IOP or factors that reduce ocular blood flow [1,2]. 
Ocular blood flow is reduced in glaucoma patients, including 
the iris, retina, optic nerve and choroid [1,3]. Nocturnal blood 
pressure dips and reduced diastolic pressure have been shown 
to be risk factors for glaucoma progression or development 
[4,5].
 These vascular risk factors are even more pronounced 
in normal tension glaucoma (NTG) patients, where an alleg-
edly “normal” IOP range is already sufficient to produce glau-
comatous damage [6-8]. Circadian fluctuation of the mean oc-
ular perfusion pressure is a consistent risk factor for NTG, [9] 
contributing to the fluctuation theory, which emphasizes the 
role of diurnal IOP fluctuations in NTG progression. Another 
theory emphasizes different thresholds of vulnerability to IOP 
levels among different individuals [10].
 While a high IOP is a predominant factor in produc-
ing glaucomatous damage in high tension glaucoma, vascular 
factors are more predominant in producing damage in NTG. It 
is logical that these different mechanisms may be responsible 
for the different patterns of visual field (VF) defect observed. 
When compared with high tension glaucoma, VF defects in 
NTG are relatively more localized and closer to fixation, and 
may be more predominant in the lower hemifield [11]. Infe-
rior nasal visual field defect and inferior altitudinal visual field 
defect is a characteristic field defect in nonarteritic anterior 
ischemic optic neuropathy (NAION) [12]. Other factors like 
haemodialysis and shock have also been found to produce VF 
changes, with VF improvements immediately after haemodi-
alysis [13,14].
 Blood flow instability not only leads to hypoperfusion 
but repeated mild reperfusion injury. An unstable oxygen sup-
ply leads to oxidative stress, where the formation of reactive 
oxygen species (ROS) damages mitochondria of RGC axons 
and the ON head [3]. If neighboring astrocytes are activated 
by either mechanical or ischemic stress, nitric oxide molecules 
will be produced, resulting in further formation of ROS. These 
ROS diffuses within axons in the retina and lateral geniculate 
nucleus to induce further apoptosis.
 We see a similar unstable perfusion setting that may 
lead to dysfunctional regulation of ocular blood flow in pa-
tients with menorrhagia, where the systemic blood pressure 
may be transiently reduced in a cyclical fashion throughout 
each menstrual period [15]. However, the pattern and nature 
of hypoperfusion in menorrhagia differs from that of NTG and 
NAION. The authors thus suspect that menorrhagia may give 
rise to a visual field anomaly different from those observed in 
NTG and NAION. In this study, we set out to look into wheth-
er ON, retinal nerve fiber layer (RNFL) and VF anomalies ex-
ist among patients with menorrhagia.
Methods
 This study adhered to the tenets of the Declaration 
of Helsinki. It has been approved by the Institutional Review 
Board of the University of Hong Kong/Hospital Authority 
Hong Kong West Cluster. The subjects’ informed consent were 
obtained and recruited at the Obstetrics and Gynaecology De-
partment and the study was conducted at the Ophthalmology 
Department in a tertiary teaching hospital between February 
2014 and December 2015. This was a cross sectional cohort 
study.
 Women suffering from ongoing menorrhagia being 
followed up at the gynecology clinic comprised of the disease 
group, while those following for other gynaecological condi-
tions with no past history of menorrhagia comprised of the 
control group. The severity of menorrhagia was assessed and 
quantified by a pictorial blood assessment chart (PBAC) de-
veloped by Higham et al.[16] The definition of menorrhagia is 
defined as blood loss of >80mL [17]. It has been shown that a 
PBAC score of >/=150 correlates well with >80mL menstrual 
blood loss as estimated by the alkaline haematin method. 18 
PBAC was either taken at the time of recruitment if the sub-
ject happened to be menstruating, or via telephone when the 
subject has her next cycle. Other inclusion criteria include an 
open angle on gonioscopy. Exclusion criteria included patients 
with pre-existing glaucoma, closed angles on gonioscopy, pa-
tients with preexisting ophthalmological diseases that would 
affect VF or optical coherence tomography (OCT) analysis, 
high myopia more than -8 diopters, patients with gynaecologi-
cal malignancy, known anaemia due to causes other than men-
orrhagia and bleeding disorders with haemoglobin levels less 
than 10g/dl.
 Consenting subjects were referred to the Ophthal-
mology outpatient clinic and examined by 2 investigators (JS 
and BC). Baseline information collected included the patient’s 
age and family history of glaucoma. Examinations performed 
included slit lamp examination, IOP measurement by Gold-
mann applanation, gonioscopy and assessment of the optic 
nerve and cup-disc ratio (CDR). Parameters recorded and in-
vestigations conducted by optometrist included visual acuity 
measurement measurement by Snellen chart, automated re-
fraction, central corneal thickness (CCT), VF test (central 24-
2, Humphrey Field Analyzer) and peripapillary retinal nerve 
fiber layer (RNFL) thickness (Spectralis spectral-domain op-
tical coherence tomography, Heidelberg Engineering, Heidel-
berg, Germany).
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PBAC score were calculated for all subjects. For patients in the 
disease group, if they required hospital admission for blood 
transfusion, data was also collected for haemoglobin and fer-
ritin levels prior to transfusion.
Statistical Analysis
 Statistical calculation was performed by a statistician. 
Only data from the patient’s left eye were analyzed to avoid 
statistical overestimation due to inter-eye correlation. Using 
Shapiro-Wilk test for pattern standard deviation (PSD), a p 
value of 1.355e-05 was obtained, therefore normality assump-
tion is violated.
 Statistical calculation was performed by a statistician. 
Only data from the patient’s left eye were analyzed to avoid 
statistical overestimation due to inter-eye correlation. Using 
Shapiro-Wilk test for pattern standard deviation (PSD), a p 
value of 1.355e-05 was obtained, therefore normality assump-
tion is violated.
 For secondary outcome, we also looked for correla-
tion between VF global indices, OCT indices and the severity 
of menorrhagia, as reflected by the PBAC score. Pearson’s cor-
relation test was used.
Results
 Twenty-six subjects were recruited into the disease 
group and 24 subjects were recruited into the control group. 
One subject was excluded from data analysis from each of the 
2 groups due to spherical equivalent showing high myopia 
more than -8 diopters, which may interfere with VF and OCT 
interpretation. Twenty-five eyes from the disease group and 23 
eyes from the control group were available for analysis. Among 
the control group, 14 subjects have already entered menopause 
and PBAC score was then taken as zero.
 The difference in mean PBAC of the disease group 
and control group was statistically significant, being 1815 +/- 
1944 for the disease group and 35.3 +/- 49.6 for the control 
group respectively. (p<0.0001) In the disease group, the aver-
age duration of active menorrhagia was 2.6 years. However, 
this data cannot be recalled in 8 subjects. Twenty-three sub-
jects from the disease group required blood transfusion for 
their severe menorrhagia, and thus pre-transfusion ferritin 
and haemoglobin levels were taken.
 The mean age, CCT and spherical equivalent were 
comparable between the disease group and control group. The 
mean age for the disease group was 45.04 +/- 7.37, while that 
for the control group was 48.39 +/- 6.61 (p=0.10, unpaired t-
test. The mean CCT for the disease group and control group 
were 548.3 +/- 26.1um and 548.9 +/- 26.1um respectively 
(p=0.9, unpaired t-test). The mean spherical equivalent for the 
disease group is -1.7 +/- 1.7D while that for the control group 
was -1.9 +/- 2.7D (p=0.8, unpaired t-test). Two patients from 
the disease group and 4 patients from the control group had 
family history of glaucoma (p=0.33, chi square test). Baseline 
demographic data and menorrhagia parameters are tabulated 
in Table 1a and Table 1b.
Table 1: Table showing baseline data for study subjects 
Disease 
group (n=25)
Control 
group (n=23)
p value
Mean age 45 +/- 7 48 +/- 6 0.1
Family his-
tory of glau-
coma
2 4 0.33#
Gonioscopy Open Open
Spherical 
equivalent 
(dioptre)
-1.7 +/- 1.7 -1.9 +/- 2.7 0.8
Central cor-
neal thick-
ness (um)
548 +/- 26 548 +/- 26 0.9
IOP (mmHg) 15 +/- 3 14 +/- 2 0.4
CDR 0.3 0.3 1.0
PBAC 1815 +/- 
1944 
35.3 +/- 49.6 <0.0001
Menorrhagia 
duration 
(years)
2.6 NA
Ferritin (ng/
mL)
44.05 +/- 
48.3 (n=23)
NA
Pre-transfu-
sion Hb (g/
dl)
8.04 +/- 1.97 
(n=23)
NA
n, number; IOP, intraocular pressure, CDR, cup-disc ratio; 
PBAC, pictorial blood assessment chart; Hb, haemoglobin; 
NA, not applicable
#chi-squared test
 Our results indicate that the VF was worse for the 
disease group when compared with control group. A signifi-
cant difference was found between the mean PSD of the dis-
ease and control group. The mean PSD value was 2.73 +/- 1.89 
and 1.81+/-0.42 for the disease and control group respectively 
(p<0.01). No significant differences were found for the mean 
MD, VFI or average RFNL thickness. (see Table 2)
 Correlation analysis shows that a more severe menor-
rhagia is associated with a worse visual field. Pearson’s correla-
tion analysis shows a negative correlation between MD and 
PBAC and between VFI and PBAC, while a positive correla-
tion between PD and PBAC was observed. This correlation 
pattern was seen both when all subjects were analyzed and 
when the disease group was analyzed. Statistical significance 
was also reached when analyzing all subjects and the disease 
group, but not within the control group. The correlation coef-
ficient for subjects and subgroup analysis is shown in Table 3. 
The scatter plots with least square fit for the patient group is 
shown in Figure 1 and those for all subjects are shown in Fig-
ure 2.
  JScholar Publishers    
Table 2: Table comparing the mean visual field global indices 
and average NFL thickness in the disease group and control 
group
Disease 
group (n=25)
Control 
group (n=23)
p value
PSD 2.73 +/- 1.9 1.82 +/- 0.42 <0.01
MD -3.0 +/- 3.3 -2.28 +/- 
1.26
0.35
VFI 95.64 +/- 7.5 97.4 +/- 1.9 0.34
NFL 105.6 +/- 
11.4
103.8 +/- 
10.0
0.57
n, number; PSD, pattern standard deviation; MD, mean de-
viation; VFI, visual field index; NFL, average nerve fiber layer 
thickness
Table 3: Table tabulating the correlation coefficient calculated 
using Pearson’s correlation analysis
All subjects 
(n = 48)
Disease 
group (n= 
25)
Control 
group 
(n= 23)
PSD against PBAC 0.63 
(<0.0001)
0.60 
(0.009)
-0.28 
(0.22)
Correlation coef-
ficient
(p value)
MD against PBAC
Correlation coef-
ficient 
(p value)
-0.61 
(0.001)
-0.68 
(0.003)
0.46 
(0.04)
VFI against PBAC
Correlation coef-
ficient 
(p value)
-0.61 
(0.003)
-0.65 
(0.009)
0.22 
(0.35
NFL against PBAC
Correlation coef-
ficient 
(p value)
-0.17 
(0.27)
-0.33 
(0.11)
0.02 
(0.93)
n, number; PSD, pattern standard deviation; PBAC, pictorial 
blood assessment chart; MD, mean deviation; VFI, visual field 
index; NFL, average nerve fiber layer thickness
A subgroup analysis within the control group was done, com-
paring the VF global indices and OCT indices between patients 
with normal menses and those who have entered menopause. 
No statistical significance was seen. (see Table 4)
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Table 4: Table comparing the mean VF indices and NFL thick-
ness between subjects with normal menses and subjects with 
menopause
Normal 
menses 
(n=9)
Menopause 
(n=14)
p value
PSD 1.66 +/- 0.44 1.95 +/- 0.38 0.15
MD -1.66 +/- 
1.33
-2.79 +/- 
0.97
0.06
VFI 97.8 +/- 1.8 97.1 +/- 2.0 0.45
NFL 104.8 +/- 
10.5
103.2 +/- 
10.1
0.72
n, number; PSD, pattern standard deviation; PBAC, pictorial 
blood assessment chart; MD, mean deviation; VFI, visual field 
index; NFL, average nerve fiber layer thickness
Discussion
 Our results demonstrate that subjects with severe 
menorrhagia had a compromised baseline VF compared to 
control, and also that more severe menorrhagia is associated 
with a poorer VF performance. 
 Although correlation analysis did not reach statistical 
significance among the control group, this is likely due to the 
fact that PBAC was taken as 0 for all menopause subjects, re-
gardless of their previous menstrual flow. As our premise was 
that menorrhagia would lead to blood flow instability and thus 
may be a risk factor for visual field defect, all subjects without 
menorrhagia (both normal menses and menopause) were in-
cluded in the correlation analysis. We do note that menopause 
subjects constitute the majority of the control group, and thus 
we have repeated the correlation analysis, this time excluding 
all menopause subjects. Results are shown in Table 5.
Table 5: Table tabulating the correlation coefficient calculated 
using Pearson’s correlation analysis, with menopause subjects 
excluded
All subjects (n= 
34)
Control group (n= 
9)
PSD against PBAC
Correlation coef-
ficient 
(p value)
0.63 (<0.003) 0.09 (0.83)
MD against PBAC
Correlation coef-
ficient 
(p value)
-0.67 (0.001) 0.14 (0.72)
VFI against PBAC
Correlation coef-
ficient 
(p value)
-0.64 (0.003) 0.21 (0.59)
NFL against PBAC
Correlation coef-
ficient 
(p value)
-0.25 (0.16) -0.2 (0.6)
n, number; PSD, pattern standard deviation; PBAC, pictorial 
blood assessment chart; MD, mean deviation; VFI, visual field 
index; NFL, average nerve fiber layer thickness
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Figure 1: Scatter plots with least square fit for the disease group
Figure 1a: Scatter plot showing a positive correlation between PBAC and left eye PSD (p=0.009)
Figure 1b: Scatter plot showing a negative correlation between PBAC and left eye MD (p=0.003)
Figure 1c: Scatter plot showing negative correlation between PBAC and left eye VFI (p=0.010)
Figure 1d: Scatter plot showing a negative correlation between PBAC and left eye average NFL thickness (p=0.11)
Figure 2 Scatter plots with least square fit for all subjects
Figure 2a: Scatter plot showing a positive correlation between PBAC and left eye PSD (p<0.0001)
Figure 2b: Scatter plot showing a negative correlation between PBAC and left eye MD (p=0.002)
Figure 2c: Scatter plot showing negative correlation between PBAC and left eye VFI (p=0.003)
Figure 2d: Scatter plot showing a negative correlation between PBAC and left eye average NFL thickness (p=0.266)
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We postulate two explanations for this. Firstly, although fer-
ritin and haemoglobin levels also reflect the severity of menor-
rhagia, most subjects are already on iron supplements, which 
may confound the results. Secondly, when compared with 
PBAC (which directly reflects the severity of menorrhagia and 
thus blood flow instability), ferritin and haemoglobin levels 
actually reflect the severity of anaemia, a consequence of men-
orrhagia rather than menorrhagia itself. 
 Although a consistently worse VF performance was 
demonstrated, none of the subjects suffering from menorrha-
gia showed signs of glaucomatous damage when assessing the 
CDR, VF and OCT. However, given the nature of reperfusion 
damage that menorrhagia results in and the compromised VF 
performance seen in our menorrhagic subjects, it is of the au-
thors’ opinion that we cannot exclude menorrhagia as a poten-
tial risk factor for developing glaucoma or glaucoma progres-
sion.
 Our results are confounded by the fact that recruit-
ed subjects, although suffering from active menorrhagia, are 
already receiving treatment (including iron supplement and 
blood transfusion) to alleviate their condition. These treat-
ments however, aim to treat the complication of menorrhagia 
(i.e. anaemia) and do not alter the fact that hypoperfusion had 
already taken place. Those suffering from severe and uncon-
trolled menorrhagia are likely to have undergone surgery, ren-
dering it difficult to recruit such subjects. The mean duration 
of menorrhagia is also rather short (2.6 years), and glaucoma 
may not have developed yet at this juncture. The authors re-
alize the relatively short duration and treated anaemia would 
affect how ideally our recruited subjects represent those with 
menorrhagia, but patients with menorrhagia are usually well 
looked after and seldom suffer from debilitating menorrhagia 
for long periods of time, rendering it difficult to study the nat-
ural course of this disease, especially in the developed country. 
Other weaknesses include the lack of sample size calculations 
and the lack of optic nerve head perfusion measurement. Be-
ing a cross-sectional study, no causality can be assumed and 
this study only serves as an interesting initial observation that 
menorrhagia subjects may have mild visual field defects. Re-
viewing our study design, it would be strengthened by prior 
sample size calculation, recruiting a larger sample size and 
having a prospective follow up of menorrhagia patients.
 For future study direction, we suggest looking into 
the impact of menorrhagia on the pattern of VF defects, VF 
progression and whether it is a possible risk factor for glauco-
ma development and progression. Studies may also look into 
changes in ocular perfusion pressure or OCT angiography in 
relation to the menstrual cycle or menorrhagia. Unlike other 
known vascular risk factors for glaucoma like arrhythmia and 
Raynaud’s phenomenon which are associated with other car-
diovascular and autoimmune diseases, patients with menor-
rhagia are essentially normal healthy subjects.
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 The pattern of results remain unchanged, reaching 
statistical significance, except in control group. This is likely 
due the fact that only 9 subjects were analyzed. A subgroup 
analysis within the control group fails to show significant dif-
ference in VF performance or NFL thickness among those 
with normal menses and menopause. This may either be due 
to a small sample size. Or it could suggest that haemodynamic 
disturbance (menorrhagia), and not the presence or absence of 
menses per se, has a role in contributing to VF damage, which 
falls in line with previous studies showing blood flow instabil-
ity as a risk factor for glaucoma [1-7,9].
 When the VF global indices were compared between 
the disease and control group, only PSD showed a significant 
difference, and not MD or VFI. This may be due to PSD mainly 
reflecting localized loss rather than diffuse loss. Different op-
tic neuropathies demonstrate different patterns of VF defects. 
Well known examples include altitudinal defects in nonarte-
ritic and centrocaecal scotomas in toxic or nutritional neu-
ropathies [19,20]. VF defects also vary among glaucomatous 
neuropathies. Superior field loss has found to been more com-
mon than inferior field loss [21]. For pigmentary glaucoma, 
the temporal field may be more susceptible to damage [22]. 
For high tension glaucoma, dense arcuate defects are more 
common, while for NTG, VF defects are relatively more local-
ized and closer to fixation [11]. We have attempted studying 
the VF defect among the disease group; unfortunately no con-
sensus could be drawn through analyzing our sample subjects. 
We postulate that a larger sample size of menorrhagia subjects, 
recruiting subjects with a longer duration or more severe men-
orrhagia may help shed light on this matter.
 Vascular factors play an important role in the devel-
opment and progression of optic neuropathy including glau-
coma. However, the damage stems not simply from ischemia 
and hypoperfusion, but from blood flow instability, which 
the body’s autoregulatory mechanism may fail to cope with. 
Risk factors for NTG offer a glimpse into this: vasospasm, 
Raynaud’s phenomenon, migraine, arrhythmia and shock etc 
[23,24]. Blood flow instability gives rise to oxidative stress and 
repeated reperfusion injury. The increased ET1, MM9 and 
proteasomes particularly affect the mitochondria function of 
the ON head [3]. Reperfusion injury occurs when blood sup-
ply returns to the tissue after a period of ischemia. The absence 
of oxygen and nutrients from the blood creates a condition 
in which the restoration of circulation results in inflamma-
tion and oxidative damage through the induction of oxidative 
stress rather than restoration of normal function. The correla-
tion between PBAC and VF global indices reaches statistical 
significance, suggesting an association between severe menor-
rhagia and a worse VF. However, the correlation did not reach 
statistical significance when ferritin and pre-transfusion hae-
moglobin levels were analyzed against VF indices.
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This may help us further understand the pathophysiology of 
glaucoma. If menorrhagia is indeed established as a risk fac-
tor for glaucoma, subjects should be warned of this risk when 
deciding their treatment options, and also offered regular oph-
thalmology checkups.
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